Early and Consistent Improvements in Urinary Symptoms and Quality of Life in Idiopathic Overactive Bladder Patients Following Repeat Treatment With OnabotulinumtoxinA: Results of a Multicenter, Randomized, Placebo-Controlled, Phase 4 Trial